Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.40% Nasdaq Up0.97%

Ambit Biosciences Corporation (AMBI)

-NGM
7.64 0.44(6.11%) Apr 22, 4:00PM EDT
Get the big picture on all your investments.
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (11,195) (26,647) (37,631)
Operating Activities, Cash Flows Provided By or Used In
Depreciation377  903  1,069  
Adjustments To Net Income(14,211)(5,238)(3,119)
Changes In Accounts Receivables(1,000)3,510  643  
Changes In Liabilities(1,532)(884)(960)
Changes In Inventories -   -   -  
Changes In Other Operating Activities320  (34)159  
Total Cash Flow From Operating Activities (27,302) (28,772) (39,626)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(613)46  (553)
Investments -   -   -  
Other Cash flows from Investing Activities(18) -  400  
Total Cash Flows From Investing Activities (631) 46   (153)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock86,428  21,588  21,697  
Net Borrowings(4,412)8,171  (3,103)
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 82,016   29,759   18,594  
Effect Of Exchange Rate Changes(375)31  (246)
Change In Cash and Cash Equivalents 53,708   1,064   (21,431)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.